4.5 Article

Small Leucine-Rich Proteoglycan PODNL1 Identified as a Potential Tumor Matrix-Mediated Biomarker for Prognosis and Immunotherapy in a Pan-Cancer Setting

Related references

Note: Only part of the references are listed.
Review Oncology

Hallmarks of Cancer: New Dimensions

Douglas Hanahan

Summary: The concept of the hallmarks of cancer is a tool for simplifying the complexity of cancer phenotypes and genotypes into basic principles. This article proposes phenotypic plasticity and disrupted differentiation as distinct hallmark capabilities, and discusses nonmutational epigenetic reprogramming and polymorphic microbiomes as enabling characteristics. Additionally, the importance of senescent cells in the tumor microenvironment is highlighted. The integrative concept of the hallmarks of cancer helps in understanding the mechanisms of cancer development and applying that knowledge to cancer medicine.

CANCER DISCOVERY (2022)

Article Oncology

Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer

Shaoquan Zheng et al.

Summary: This study reveals the important role of cancer-associated fibroblasts (CAFs) in TNBC and their correlation with tumor progression and the tumor microenvironment. The researchers also identify biglycan (BGN), a soluble secreted protein, as an upregulated marker in CAFs and suggest its potential as a prognostic marker and therapeutic target in TNBC.

ONCOIMMUNOLOGY (2022)

Article Immunology

Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma

Yi Wang et al.

Summary: This study identified four immunometabolism subtypes of clear cell renal cell carcinoma, revealing the interplay between immune and metabolic activities and providing new insights into personalized therapy selection.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer

Yang Chen et al.

Summary: Pancreatic cancer cells produce a unique Col1 homotrimer which promotes tumor growth and affects tumor microbiome and immunity. Deletion of Col1 homotrimer improves survival in mice and enhances the efficacy of anti-PD-1 immunotherapy.

CANCER CELL (2022)

Article Biochemistry & Molecular Biology

PODNL1 promotes cell migration and regulates the epithelial/mesenchymal transition process in bladder cancer

Xiao Liu et al.

Summary: PODNL1 has been identified as a potential therapeutic target and prognostic biomarker for bladder cancer (BLCA). Its high expression is associated with the clinical and pathological characteristics of BLCA, as well as poor prognosis. It plays a role in regulating the proliferation, migration, and epithelial mesenchymal transition (EMT) process of BLCA cells.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Review Biochemistry & Molecular Biology

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy

Yuze Wu et al.

Summary: This review focuses on the classification and inhibitory function of myeloid-derived suppressor cells (MDSCs) in immune checkpoint inhibitor (ICI) therapy, as well as the crosstalk between MDSCs and other myeloid cells. Recent findings suggest that targeting MDSCs may be a promising approach to enhance the efficacy of cancer immunotherapy.

MOLECULAR CANCER (2022)

Article Oncology

TGF-β signaling networks in the tumor microenvironment

Max Kam-Kwan Chan et al.

Summary: Transforming growth factor-beta (TGF-beta) signaling plays important roles in cancer, both as a suppressor and a promoter. Disruption of TGF-beta signaling leads to complex anti-cancer and pro-tumoral outcomes, highlighting the need for a better understanding of its molecular mechanisms for the development of effective cancer therapies.

CANCER LETTERS (2022)

Review Cell Biology

LRG1: an emerging player in disease pathogenesis

Carlotta Camilli et al.

Summary: LRG1 is a secreted glycoprotein that plays an important role in multiple human conditions, including cancer, diabetes, cardiovascular disease, neurological disease, and inflammatory disorders. While LRG1 is essentially redundant in development and homeostasis, emerging data suggest its novel role in innate immunity and tissue integrity. LRG1 is also discussed as a potential biomarker for diagnosis, prognosis, and monitoring of various conditions.

JOURNAL OF BIOMEDICAL SCIENCE (2022)

Article Biochemistry & Molecular Biology

PODNL1 Methylation Serves as a Prognostic Biomarker and Associates with Immune Cell Infiltration and Immune Checkpoint Blockade Response in Lower-Grade Glioma

Humaira Noor et al.

Summary: The study found that the methylation levels of PODNL1 CpG sites are associated with clinical outcomes in LGG, with low methylation levels correlating with unfavorable overall survival and disease-free survival. High PODNL1 expression and low-methylation of PODNL1 CpG sites are associated with significantly increased expression of immune checkpoint related genes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biology

Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer

Xiaoding Hu et al.

Summary: Research shows that the proteoglycan decorin is downregulated in tumors of patients with inflammatory breast cancer. Decorin acts as a tumor suppressor in IBC cells by affecting the E-cadherin-EGFR signaling axis, offering potential therapeutic strategies for this aggressive form of breast cancer.

COMMUNICATIONS BIOLOGY (2021)

Article Cell & Tissue Engineering

CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance

Cheng Wang et al.

Summary: Cancer stem cells (CSCs) evade immune surveillance by upregulating the immune checkpoint molecule CD276, but can be eliminated by anti-CD276 antibodies, inhibiting tumor growth and lymph node metastases. Targeting CD276 may reduce CSCs in head and neck squamous cell carcinoma (HNSCC).

CELL STEM CELL (2021)

Article Cell Biology

Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance

Sandeep Appunni et al.

Summary: Biglycan, as a class I SLRP, is a key component of the ECM involved in scaffolding collagen fibrils and mediating cell signaling. Dysregulation of its expression can lead to various clinical conditions including metabolic disorders, inflammatory disorders, musculoskeletal defects, and malignancies. Biglycan interacts with TLR-2 and TLR-4 on immune cells to induce inflammation, and its dysregulation is also observed in inflammatory metabolic conditions and cancer, where high expression levels facilitate tumor growth and metastasis.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)

Review Oncology

The matrix in cancer

Thomas R. Cox

Summary: Alterations in the extracellular matrix play a crucial role in the development and progression of solid tumours, and our understanding of matrix biology is expanding. New approaches targeting the matrix in cancer are being developed.

NATURE REVIEWS CANCER (2021)

Article Biochemistry & Molecular Biology

TIMER2.0 for analysis of tumor-infiltrating immune cells

Taiwen Li et al.

NUCLEIC ACIDS RESEARCH (2020)

Article Public, Environmental & Occupational Health

Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients

Nina Gran Egeland et al.

CLINICAL EPIDEMIOLOGY (2020)

Review Biochemistry & Molecular Biology

Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors

Alexandre Perrier et al.

BIOMOLECULES (2020)

Article Genetics & Heredity

COL5A1 may contribute the metastasis of lung adenocarcinoma

Weibo Liu et al.

Review Biochemistry & Molecular Biology

Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics

Ellen Pure et al.

ONCOGENE (2018)

Review Multidisciplinary Sciences

Cancer immunotherapy using checkpoint blockade

Antoni Ribas et al.

SCIENCE (2018)

Article Multidisciplinary Sciences

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan et al.

NATURE (2018)

Article Biochemistry & Molecular Biology

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Peng Jiang et al.

NATURE MEDICINE (2018)

Review Medicine, General & Internal

Stromal Modulators of TGF-β in Cancer

Brunella Costanza et al.

JOURNAL OF CLINICAL MEDICINE (2017)

Review Oncology

Tumor microenvironment and therapeutic response

Ting Wu et al.

CANCER LETTERS (2017)

Review Biochemistry & Molecular Biology

The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly

Shoujun Chen et al.

FEBS JOURNAL (2013)

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara et al.

NATURE COMMUNICATIONS (2013)

Article Biochemistry & Molecular Biology

Podocan-like protein: A novel small leucine-rich repeat matrix protein in bone

Yoshiyuki Mochida et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)

Article Biochemical Research Methods

Molecular signatures database (MSigDB) 3.0

Arthur Liberzon et al.

BIOINFORMATICS (2011)

Article Multidisciplinary Sciences

Integrated genomic analyses of ovarian carcinoma

D. Bell et al.

NATURE (2011)

Review Biochemistry & Molecular Biology

Biological functions of the small leucine-rich proteoglycans: From genetics to signal transduction

Liliana Schaefer et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Biochemistry & Molecular Biology

A novel modulatory mechanism of transforming growth factor-ß signaling through decorin and LRP-1

Claudio Cabello-Verrugio et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Medicine, Research & Experimental

TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression

BW Tang et al.

JOURNAL OF CLINICAL INVESTIGATION (2003)